We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Grants Petition for Amended Labeling of Dopamine Agonist Drugs
FDA Grants Petition for Amended Labeling of Dopamine Agonist Drugs
The FDA has granted part of a citizen petition calling for a safety warning on certain dopamine agonist drugs on the risks of impulse-control disorders (ICD)s for patients taking the drugs for restless legs syndrome (RLS).